Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease

Published:2014-12 Issue:6 Volume:86 Page:1244-1252
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Spithoven Edwin M., ,Kramer Anneke,Meijer Esther,Orskov Bjarne,Wanner Christoph,Caskey Fergus,Collart Frederic,Finne Patrik,Fogarty Damian G.,Groothoff Jaap W.,Hoitsma Andries,Nogier Marie-Béatrice,Postorino Maurizio,Ravani Pietro,Zurriaga Oscar,Jager Kitty J.,Gansevoort Ron T.

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

2. Autosomal dominant polycystic kidney disease;Gabow;N Engl J Med,1993

3. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980;Iglesias;Am J Kidney Dis,1983

4. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group;Hateboer;Lancet,1999

5. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study;Schrier;J Am Soc Nephrol,2002

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Native nephrectomies in patients with autosomal dominant polycystic kidney disease: retrospective cohort study;Irish Journal of Medical Science (1971 -);2024-08-12

2. Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease;Medicina Clínica;2024-07

3. Long-term effectiveness and safety of tolvaptan in autosomal dominant polycystic kidney disease;Medicina Clínica (English Edition);2024-07

4. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23

5. Cross-Species Insights into Autosomal Dominant Polycystic Kidney Disease: Provide an Alternative View on Research Advancement;International Journal of Molecular Sciences;2024-05-22